CDX2 and colorectal carcinoma: Similarly, a significant difference in the 5-year DFS was found in a validation cohort of 121 CRC-II patients when corresponding formalin-fixed paraffin-embedded (FFPE) tissues were tested using IHC with 15 CDX2-negative tumour patients.